Treatment of Allergic Rhinitis
- PMID: 26760413
Treatment of Allergic Rhinitis
Abstract
Allergic rhinitis is a common and chronic immunoglobulin E-mediated respiratory illness that can affect quality of life and productivity, as well as exacerbate other conditions such as asthma. Treatment should be based on the patient's age and severity of symptoms. Patients should be educated about their condition and advised to avoid known allergens. Intranasal corticosteroids are the most effective treatment and should be first-line therapy for persistent symptoms affecting quality of life. More severe disease that does not respond to intranasal corticosteroids should be treated with second-line therapies, including antihistamines, decongestants, cromolyn, leukotriene receptor antagonists, and nonpharmacologic therapies such as nasal irrigation. Subcutaneous or sublingual immunotherapy should be considered if usual treatments do not adequately control symptoms and in patients with allergic asthma. Evidence does not support the use of mite-proof impermeable mattresses and pillow covers, breastfeeding, air filtration systems, or delayed exposure to solid foods in infancy or to pets in childhood.
Comment in
-
Optimal Technique for Application of Corticosteroid Nasal Spray.Am Fam Physician. 2016 Aug 1;94(3):185. Am Fam Physician. 2016. PMID: 27479617 No abstract available.
Similar articles
-
Treatment of allergic rhinitis.Am Fam Physician. 2010 Jun 15;81(12):1440-6. Am Fam Physician. 2010. PMID: 20540482 Review.
-
Clinical practice guideline: Allergic rhinitis.Otolaryngol Head Neck Surg. 2015 Feb;152(1 Suppl):S1-43. doi: 10.1177/0194599814561600. Otolaryngol Head Neck Surg. 2015. PMID: 25644617
-
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352. doi: 10.1002/alr.22073. Int Forum Allergy Rhinol. 2018. PMID: 29438602 Free PMC article.
-
Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.Postgrad Med. 2017 Aug;129(6):581-589. doi: 10.1080/00325481.2017.1308208. Epub 2017 Mar 27. Postgrad Med. 2017. PMID: 28326908 Review.
-
Management of allergic rhinitis in the era of effective over-the-counter treatments.Postgrad Med. 2017 Aug;129(6):572-580. doi: 10.1080/00325481.2017.1333384. Epub 2017 Jun 9. Postgrad Med. 2017. PMID: 28532204 Review.
Cited by
-
Local Allergic Rhinitis-A Challenge for Allergology and Otorhinolaryngology Cooperation (Scoping Review).Life (Basel). 2024 Jul 31;14(8):965. doi: 10.3390/life14080965. Life (Basel). 2024. PMID: 39202707 Free PMC article. Review.
-
A randomized, double-blind, placebo-controlled study to evaluate the benefits of a standardized Nigella sativa oil containing 5% thymoquinone in reducing the symptoms of seasonal allergy.Medicine (Baltimore). 2024 Aug 9;103(32):e39243. doi: 10.1097/MD.0000000000039243. Medicine (Baltimore). 2024. PMID: 39121267 Free PMC article. Clinical Trial.
-
Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden.Clinicoecon Outcomes Res. 2024 Jun 10;16:493-506. doi: 10.2147/CEOR.S462698. eCollection 2024. Clinicoecon Outcomes Res. 2024. PMID: 38882235 Free PMC article.
-
Identification of Hit Compounds Using Artificial Intelligence for the Management of Allergic Diseases.Int J Mol Sci. 2024 Feb 14;25(4):2280. doi: 10.3390/ijms25042280. Int J Mol Sci. 2024. PMID: 38396957 Free PMC article.
-
Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.Front Immunol. 2023 Dec 15;14:1274241. doi: 10.3389/fimmu.2023.1274241. eCollection 2023. Front Immunol. 2023. PMID: 38162647 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
